NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $29,771,000 | +25.8% | 7,834,551 | +78.4% | 0.04% | +54.2% |
| Q1 2022 | $23,665,000 | -48.8% | 4,390,618 | +28.4% | 0.02% | -46.7% |
| Q4 2021 | $46,201,000 | -32.2% | 3,419,729 | -9.9% | 0.04% | -38.4% |
| Q3 2021 | $68,182,000 | +22.1% | 3,796,316 | +16.6% | 0.07% | +21.7% |
| Q2 2021 | $55,863,000 | -32.7% | 3,255,398 | -21.5% | 0.06% | -40.0% |
| Q1 2021 | $82,962,000 | +27.9% | 4,148,080 | +8.8% | 0.10% | +16.3% |
| Q4 2020 | $64,842,000 | +29.3% | 3,814,215 | +26.2% | 0.09% | +7.5% |
| Q3 2020 | $50,145,000 | -36.3% | 3,022,610 | -11.1% | 0.08% | -41.2% |
| Q2 2020 | $78,722,000 | +74.7% | 3,399,045 | +34.7% | 0.14% | +33.3% |
| Q1 2020 | $45,058,000 | -29.7% | 2,524,235 | -15.0% | 0.10% | -6.4% |
| Q4 2019 | $64,096,000 | +32.4% | 2,969,452 | +11.8% | 0.11% | +19.8% |
| Q3 2019 | $48,400,000 | -54.7% | 2,657,141 | -11.6% | 0.09% | -55.0% |
| Q2 2019 | $106,953,000 | +48.1% | 3,005,999 | +39.9% | 0.20% | +40.3% |
| Q1 2019 | $72,212,000 | -4.9% | 2,149,180 | -6.9% | 0.14% | -20.0% |
| Q4 2018 | $75,902,000 | -39.8% | 2,309,172 | +11.6% | 0.18% | -23.4% |
| Q3 2018 | $126,120,000 | +244.8% | 2,068,900 | +176.2% | 0.24% | +209.2% |
| Q2 2018 | $36,580,000 | -53.0% | 749,124 | +2.4% | 0.08% | -57.5% |
| Q1 2018 | $77,770,000 | -23.7% | 731,882 | -57.1% | 0.18% | -26.0% |
| Q4 2017 | $101,860,000 | +156.3% | 1,705,632 | +3.0% | 0.24% | +137.3% |
| Q3 2017 | $39,749,000 | +17.3% | 1,656,210 | -4.4% | 0.10% | +13.3% |
| Q2 2017 | $33,882,000 | -35.8% | 1,733,110 | -23.0% | 0.09% | -38.4% |
| Q1 2017 | $52,806,000 | +106.6% | 2,249,950 | +8.0% | 0.15% | +92.1% |
| Q4 2016 | $25,564,000 | -15.3% | 2,083,429 | +18.6% | 0.08% | -15.6% |
| Q3 2016 | $30,183,000 | +8.7% | 1,756,873 | -9.9% | 0.09% | +3.4% |
| Q2 2016 | $27,762,000 | -9.7% | 1,950,931 | -12.8% | 0.09% | -12.1% |
| Q1 2016 | $30,756,000 | -81.0% | 2,236,773 | -76.7% | 0.10% | -76.4% |
| Q4 2015 | $161,745,000 | +42.1% | 9,599,117 | -7.6% | 0.42% | +27.3% |
| Q3 2015 | $113,816,000 | -6.5% | 10,384,680 | +6.8% | 0.33% | +4.4% |
| Q2 2015 | $121,677,000 | +75.4% | 9,726,344 | +54.3% | 0.32% | +54.9% |
| Q1 2015 | $69,356,000 | -10.8% | 6,305,115 | +25.8% | 0.20% | -22.1% |
| Q4 2014 | $77,713,000 | +4.9% | 5,013,721 | -18.3% | 0.26% | -10.0% |
| Q3 2014 | $74,062,000 | +9.9% | 6,136,021 | +16.7% | 0.29% | +3.9% |
| Q2 2014 | $67,392,000 | +24.7% | 5,256,759 | +17.9% | 0.28% | +17.6% |
| Q1 2014 | $54,055,000 | +10.4% | 4,459,959 | +3.4% | 0.24% | +0.4% |
| Q4 2013 | $48,978,000 | +50.1% | 4,315,203 | +38.1% | 0.24% | +33.9% |
| Q3 2013 | $32,641,000 | +26.7% | 3,125,060 | +40.1% | 0.18% | +5.4% |
| Q2 2013 | $25,765,000 | – | 2,230,699 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |